A - Agilent Technologies - Stock Forecast

Healthcare - Sector
Coverage Profile Performance Price Targets & Ratings Chart Insider Trading

A is currently covered by 18 analysts with an average price target of $158.69. This is a potential upside of $14.23 (9.85%) from yesterday's end of day stock price of $144.46.

Agilent Technologies's activity chart (see below) currently has 207 price targets and 177 ratings on display. The stock rating distribution of A is 28.99% HOLD, 55.07% BUY and 15.94% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 81.84% with an average time for these price targets to be met of 218.87 days.

Highest price target for A is $165, Lowest price target is $120, average price target is $158.69.

Most recent stock forecast was given by DANIEL ARIAS from STIFEL on 05-Apr-2024. First documented stock forecast 15-Aug-2013.


Agilent Technologies is a company that offers a wide range of application-focused solutions to the life sciences, diagnostics, and applied chemical.

The company operates through three segments, namely, Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab.

The Life Sciences and Applied Markets segment

Offers a range of analytical instruments and solutions to scientists and researchers in the fields of liquid and gas chromatography, mass spectrometry, atomic absorption, and plasma spectroscopy.

The segment’s portfolio includes liquid chromatography systems, gas chromatography systems, inductively coupled plasma mass spectrometry instruments, atomic absorption instruments, microwave plasma-atomic emission spectrometry instruments, inductively coupled plasma optical emission spectrometry instruments, and raman spectroscopy.

The segment also offers cell analysis plate-based assays, flow cytometers, real-time cell analyzers, cell imaging systems, microplate readers, laboratory software, information management and analytics, laboratory automation and robotic systems, dissolution testing, vacuum pumps, and measurement technologies.

The Diagnostics and Genomics segment

Offers a range of products and services for molecular and clinical diagnostics including:

  • DNA mutation, genotyping, gene copy number, gene rearrangements.
  • DNA methylation, gene expression, next-generation sequencing, target enrichment, interpretation support software.
  • Immunohistochemistry in situ hybridization, hematoxylin, eosin, and special staining.
  • software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry.
  • Liquid-based pharmacodiagnostics.

The Agilent CrossLab segment

Provides a range of products and services to support laboratory operations and research, including:

  • GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies.
  • Startup, operational, training, compliance support, software as a service, asset management, and consultation services.


The company was incorporated in 1999 and is headquartered in Santa Clara, California.

Currently out of the existing stock ratings of A, 20 are a HOLD (28.99%), 38 are a BUY (55.07%), 11 are a SELL (15.94%).

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$18.54 (12.83%)


8 days ago

7/9 (77.78%)

$21.66 (15.32%)




$-12.46 (-8.63%)


1 months 16 days ago

7/8 (87.5%)

$-5.01 (-3.66%)




$-19.46 (-13.47%)


1 months 16 days ago

10/12 (83.33%)

$-12.01 (-8.77%)




$-24.46 (-16.93%)


2 months 19 days ago

4/6 (66.67%)

$-9.88 (-7.61%)




$20.54 (14.22%)


3 months 24 days ago

6/9 (66.67%)

$27.05 (19.61%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is A (Agilent Technologies) average time for price targets to be met?

On average it took 218.87 days on average for the stock forecasts to be realized with a an average price target met ratio 81.84

Which analyst has the current highest performing score on A (Agilent Technologies) with a proven track record?


Which analyst has the most public recommendations on A (Agilent Technologies)?

Dan Brennan works at UBS and has 4456 price targets and 3740 ratings on A

Which analyst is the currently most bullish on A (Agilent Technologies)?

Doug Schenkel with highest potential upside - $55.54

Which analyst is the currently most reserved on A (Agilent Technologies)?

Isaac Ro with lowest potential downside - -$91.46

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?